Trinity Biotech Corp (TRIB): Net earnings per share (EPS TTM)

Trinity Biotech plc is an Irish manufacturer of diabetes and HIV tests that maintains pricing power due to laboratory trust. Product assembly is conducted at its own factories with moderate reliance on external reagent suppliers. The rolling net income per share reflects the performance of modernized filling lines, while the value of -52.65 reflects the metric's balance in the current period.

Net income per share over 12 months determines the specific fundamental earnings of the business allocated to a single security. By analyzing the trend of rolling net income per share, an investor can see the real return on capital relative to total revenue. This metric is calculated by dividing the total annual profit by the number of shares outstanding. For Trinity Biotech plc (TRIB), this indicator reflects the resilience of earnings to external shocks. Geopolitical instability and sanctions limiting the sale of diagnostic systems directly pressure the final value of this metric.